http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.jpg 144 ALBANY, New York, May 30, 2013 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that Thomas E. D'Ambra, Ph.D., Chairman, President and Chief Executive Officer at AMRI, will present at the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12699 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12699 Thu, 30 May 2013 13:00:00 +0100 LEXINGTON, Massachusetts, May 30, 2013 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12697 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12697 Thu, 30 May 2013 12:00:00 +0100 - Will Establish Valeant as a Global Leader in Eye Health as Well as Dermatology- Expected to Achieve Annual Cost Savings of at Least $800 Million http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12665 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12665 Mon, 27 May 2013 13:00:00 +0100 ALBANY, New York, May 15, 2013 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that Michael M. Nolan, Vice President, Chief Financial Officer and Treasurer at AMRI, will present at the UBS... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12572 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12572 Wed, 15 May 2013 13:00:00 +0100 DUBLIN, May 14, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will participate in three upcoming investor events. A live audio webcast of each... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12557 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12557 Tue, 14 May 2013 02:43:00 +0100 -- Company Reports Total Revenues of $196 Million Driven by Record Net Sales of Xyrem and Erwinaze http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12519 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12519 Tue, 07 May 2013 22:52:00 +0100 -- Total First Quarter Revenue up 11% at $59.4 Million and Adjusted EPS increased to $0.23 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12506 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12506 Tue, 07 May 2013 13:00:00 +0100 COPENHAGEN, Denmark, May 2, 2013 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12479 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12479 Thu, 02 May 2013 12:33:00 +0100 - Reports First-Quarter Adjusted EPS of $0.68, GAAP EPS of $0.60 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12435 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12435 Fri, 26 Apr 2013 12:51:00 +0100 ALBANY, New York, April 24, 2013 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue first quarter financial results before the opening of the market on Tuesday, May 7, 2013.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12416 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12416 Wed, 24 Apr 2013 13:00:00 +0100 DUBLIN, April 23, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its first quarter 2013 financial results on Tuesday, May 7, 2013, after the close... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12404 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12404 Tue, 23 Apr 2013 21:05:00 +0100 ALBANY, New York, April 23, 2013 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that AMRI Chairman, President and Chief Executive Officer Thomas E. D'Ambra, Ph.D. will present at the 12th... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12400 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12400 Tue, 23 Apr 2013 13:00:00 +0100 MCKINNEY, Texas, April 18, 2013 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) announces the following webcast:If you are unable to participate during the live webcast, the call will be... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12353 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12353 Thu, 18 Apr 2013 12:00:00 +0100 - First-Quarter Ongoing EPS of $0.42 (GAAP EPS of $0.34) - http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12344 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12344 Wed, 17 Apr 2013 13:08:00 +0100 - Frost & Sullivan hosts complimentary webinar evaluating the digitization of healthcare in a key emerging marketKUALA LUMPUR, Malaysia, April 17, 2013 /PRNewswire/ -- As the healthcare industry... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12335 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12335 Wed, 17 Apr 2013 06:15:00 +0100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12325 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12325 Tue, 16 Apr 2013 12:00:00 +0100 - WHEN: April 4, 2013 at 4pm BST- WHERE: Online, with free registration http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12185 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12185 Wed, 27 Mar 2013 12:56:00 +0000 - Frost & Sullivan hosts a complimentary webinar discussing emerging trends, regulations and providing forward projections for the Latin American EMR market. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12111 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/12111 Tue, 19 Mar 2013 19:14:00 +0000 DUBLIN, Feb. 27, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the company will participate in two upcoming investor conferences. A live webcast of each... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11908 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11908 Wed, 27 Feb 2013 14:00:00 +0000 - Record Total Revenues of $586 Million in 2012 - http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11890 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11890 Tue, 26 Feb 2013 22:45:00 +0000 ATLANTA, Feb. 20, 2013 /PRNewswire/ -- Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11844 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11844 Wed, 20 Feb 2013 12:30:00 +0000 DUBLIN, Ireland, February 14, 2013 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11803 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11803 Thu, 14 Feb 2013 12:05:00 +0000 -- Provides Guidance for Full Year 2013 Adjusted EPS of $0.43 at Mid-Point http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11786 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11786 Tue, 12 Feb 2013 13:00:00 +0000 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11782 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11782 Mon, 11 Feb 2013 21:05:00 +0000 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11643 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11643 Mon, 28 Jan 2013 12:16:00 +0000 - Fourth-Quarter Ongoing EPS of $1.51 (GAAP EPS of $0.66) - http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11609 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11609 Wed, 23 Jan 2013 12:55:00 +0000 ALBANY, New York, Jan. 15, 2013 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year financial results before the opening of the market on Tuesday,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11539 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11539 Tue, 15 Jan 2013 13:00:00 +0000 DUBLIN, January 8, 2013 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11491 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11491 Tue, 08 Jan 2013 17:01:00 +0000 LUGANO, Switzerland, January 7, 2013 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11468 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11468 Mon, 07 Jan 2013 12:50:00 +0000 -- Frost & Sullivan hosts complimentary webinar discussing the enablement of remote monitoring through mHealth technologies http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11201 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11201 Thu, 29 Nov 2012 12:55:00 +0000 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11157 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11157 Mon, 26 Nov 2012 15:50:00 +0000 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11125 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11125 Tue, 20 Nov 2012 20:01:00 +0000 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11086 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11086 Thu, 15 Nov 2012 22:34:00 +0000 -- Company Reports Revenues of $176 Million, Excluding $8 Million from the Women's Health Discontinued Operations -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11020 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/11020 Thu, 08 Nov 2012 23:03:00 +0000 - Increases 2012 EPS Guidance, Including Higher 2012 Royalty Revenue Guidance; Tightens Range for 2012 Contract Revenue GuidanceALBANY, New York, Nov. 6, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10980 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10980 Tue, 06 Nov 2012 13:00:00 +0000 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10929 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10929 Wed, 31 Oct 2012 23:30:00 +0000 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10896 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10896 Mon, 29 Oct 2012 20:37:00 +0000 - Third-Quarter Ongoing EPS of $1.30 (GAAP EPS of $1.21), an Increase of 10.2 Percent and Exceeding the Company's Quarterly Guidance Range - http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10756 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10756 Wed, 17 Oct 2012 12:44:00 +0100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10753 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10753 Wed, 17 Oct 2012 12:00:00 +0100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10620 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10620 Wed, 03 Oct 2012 14:00:00 +0100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10544 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10544 Thu, 27 Sep 2012 08:00:00 +0100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10418 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10418 Thu, 13 Sep 2012 13:00:00 +0100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10213 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10213 Fri, 24 Aug 2012 14:00:00 +0100 - Company Reports Total Revenues of $130 Million http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10108 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10108 Tue, 07 Aug 2012 23:39:00 +0100 ALBANY, New York, Aug. 1, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2012. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10082 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10082 Wed, 01 Aug 2012 13:00:00 +0100 DUBLIN, August 1, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10079 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10079 Wed, 01 Aug 2012 12:00:00 +0100 SCHLIEREN, Switzerland, July 30, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10059 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10059 Mon, 30 Jul 2012 06:39:00 +0100 MCKINNEY, Texas, July 25, 2012 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended June 30, 2012, net income was $1.32 per share, compared with $1.27 per... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10034 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10034 Wed, 25 Jul 2012 21:54:00 +0100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10028 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/10028 Wed, 25 Jul 2012 13:00:00 +0100 - Second-Quarter Ongoing EPS of $1.23, an Increase of Nearly 10 Percent and Exceeding the Company's Quarterly Guidance Range; GAAP EPS of $1.08 - http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9982 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9982 Wed, 18 Jul 2012 12:47:00 +0100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9754 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9754 Tue, 19 Jun 2012 13:30:00 +0100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9674 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9674 Tue, 12 Jun 2012 13:00:00 +0100 - Frost & Sullivan hosts complimentary webinar introducing recent infectious diseases and in-vitro diagnostics analysis focused on the APAC market http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9639 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9639 Thu, 07 Jun 2012 15:59:00 +0100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9527 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9527 Thu, 24 May 2012 14:00:00 +0100 - Key considerations and survival techniques in a market that is consolidating fast http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9460 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9460 Thu, 17 May 2012 12:30:00 +0100 ALBANY, New York, May 9, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2012. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9389 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9389 Wed, 09 May 2012 13:00:00 +0100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9343 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9343 Wed, 02 May 2012 13:54:00 +0100 MCKINNEY, Texas, April 24, 2012 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended March 31, 2012, net income was $1.17 per share, compared with $.84 per... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9282 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9282 Tue, 24 Apr 2012 22:11:00 +0100 CALGARY, Alberta, April 19, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9239 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9239 Thu, 19 Apr 2012 14:00:00 +0100 - Frost & Sullivan hosts complimentary webinar highlighting recent United States clinical laboratory market analysis http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9236 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9236 Thu, 19 Apr 2012 12:45:00 +0100 -- First Quarter Ongoing EPS of $1.03, Up 13.2 Percent -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9210 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9210 Wed, 18 Apr 2012 12:44:00 +0100 MCKINNEY, Texas, April 18, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9208 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9208 Wed, 18 Apr 2012 12:00:00 +0100 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9179 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9179 Mon, 16 Apr 2012 16:31:00 +0100 DUBLIN, April 12, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9155 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9155 Thu, 12 Apr 2012 16:15:00 +0100 ALBANY, New York, March 28, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9054 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/9054 Wed, 28 Mar 2012 13:00:00 +0100 LONDON, March 21, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8989 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8989 Wed, 21 Mar 2012 11:30:00 +0000 INDIANAPOLIS, March 19, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8951 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8951 Mon, 19 Mar 2012 08:00:00 +0000 LEUVEN, Belgium, March 16, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8940 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8940 Fri, 16 Mar 2012 06:15:00 +0000 LEUVEN, Belgium, March 16, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8941 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8941 Fri, 16 Mar 2012 06:15:00 +0000 GALWAY, Ireland, February 29, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8823 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8823 Wed, 29 Feb 2012 06:30:00 +0000 ABBOTT PARK, Illinois and MECHELEN, Belgium, February 29, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8824 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8824 Wed, 29 Feb 2012 06:30:00 +0000 DUBLIN, February 27, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8809 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8809 Mon, 27 Feb 2012 22:03:00 +0000 MCKINNEY, Texas, February 9, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8724 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8724 Thu, 09 Feb 2012 21:32:00 +0000 ALBANY, New York, February 7, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8696 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8696 Tue, 07 Feb 2012 13:00:00 +0000 ALBANY, New York, January 31, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8653 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8653 Tue, 31 Jan 2012 13:00:00 +0000 MCKINNEY, Texas, January 30, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8644 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8644 Mon, 30 Jan 2012 12:00:00 +0000 THOUSAND OAKS, California, and ROCKVILLE, Maryland, January 26, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8632 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8632 Thu, 26 Jan 2012 14:36:00 +0000 ABBOTT PARK, Illinois, January 25, 2012 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8622 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8622 Wed, 25 Jan 2012 12:46:00 +0000 SKILLMAN, New Jersey, November 10, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8232 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8232 Thu, 10 Nov 2011 15:19:00 +0000 MCKINNEY, Texas, October 26, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8105 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8105 Wed, 26 Oct 2011 21:31:00 +0100 PRINCETON, New Jersey, October 26, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8104 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8104 Wed, 26 Oct 2011 15:53:00 +0100 ABBOTT PARK, Illinois, October 19, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8038 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8038 Wed, 19 Oct 2011 13:57:00 +0100 ABBOTT PARK, Illinois, October 19, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8037 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/8037 Wed, 19 Oct 2011 12:41:00 +0100 DUBLIN, Ireland, October 13, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7998 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7998 Thu, 13 Oct 2011 12:00:00 +0100 VENLO, The Netherlands, October 7, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7962 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7962 Fri, 07 Oct 2011 18:27:00 +0100 FRAMINGHAM, Massachusetts and SYDNEY, October 2, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7910 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7910 Sun, 02 Oct 2011 11:00:00 +0100 SKILLMAN, New Jersey, August 18, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7643 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7643 Thu, 18 Aug 2011 17:53:00 +0100 AMSTERDAM, August 3, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7571 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7571 Wed, 03 Aug 2011 16:51:00 +0100 MCKINNEY, Texas, July 25, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7516 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7516 Mon, 25 Jul 2011 12:00:00 +0100 ABBOTT PARK, Illinois, July 20, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7499 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7499 Wed, 20 Jul 2011 12:36:00 +0100 DUBLIN, July 15, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7458 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7458 Fri, 15 Jul 2011 12:19:00 +0100 SKILLMAN, New Jersey, June 14, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7261 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7261 Tue, 14 Jun 2011 15:00:00 +0100 ISTANBUL, June 13, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7244 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7244 Mon, 13 Jun 2011 13:00:00 +0100 FRANKFURT, Germany, June 8, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7225 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/7225 Wed, 08 Jun 2011 18:30:00 +0100 ABBOTT PARK, Illinois, April 29, 2011 /PRNewswire/ -- Healthy performance across Abbott's diverse businesses and emerging markets expansion drove strong and consistent growth in 2010, Chairman... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6929 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6929 Fri, 29 Apr 2011 18:30:00 +0100 BAGSVAERD, Denmark, April 28, 2011 /PRNewswire/ -- Sales increased by 15% in Danish kroner and by 11% in local currencies. - Sales of modern insulins increased by 14% (11% in local currencies). http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6924 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6924 Thu, 28 Apr 2011 08:37:00 +0100 MCKINNEY, Texas, April 26, 2011 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended March 31, 2011, net income was $1.33 per share, compared with $1.46... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6915 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6915 Tue, 26 Apr 2011 21:00:00 +0100 SKILLMAN, New Jersey, April 25, 2011 /PRNewswire/ -- ConvaTec Healthcare today announced that it will report its 2010 year-end earnings on Thursday, April 28, 2011. David Johnson, CEO and George... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6907 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6907 Mon, 25 Apr 2011 14:22:00 +0100 ABBOTT PARK, Illinois, April 20, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6887 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6887 Wed, 20 Apr 2011 12:24:00 +0100 MCKINNEY, Texas, February 9, 2011 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended December 31, 2010, net income was $1.91 per share, compared with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6437 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6437 Wed, 09 Feb 2011 21:36:00 +0000 ABBOTT PARK, Illinois, January 26, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2010. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6365 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6365 Wed, 26 Jan 2011 12:44:00 +0000 OTTAWA, January 21, 2011 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6343 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6343 Fri, 21 Jan 2011 05:44:00 +0000 BRISBANE, California, December 17, 2010 /PRNewswire/ -- -- Conference call and webcast today at 8:30 a.m. EST to discuss positive CHMP opinion -- InterMune, Inc. (Nasdaq: ITMN) today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6191 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6191 Fri, 17 Dec 2010 12:00:00 +0000 BRISBANE, California, December 17, 2010 /PRNewswire/ -- -- Esbriet to be the first medicine approved for IPF patients in the EU -- InterMune, Inc. (Nasdaq: ITMN) today announced that the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6189 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6189 Fri, 17 Dec 2010 11:37:00 +0000 WASHINGTON, November 29, 2010 /PRNewswire/ -- On the eve of World AIDS Day December 1st, AIDS Healthcare Foundation (http://www.aidshealth.org) (AHF), the largest global AIDS organization,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6075 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6075 Mon, 29 Nov 2010 15:00:00 +0000 SAN FRANCISCO, November 22, 2010 /PRNewswire/ -- The International Federation of Health Plans today released its 2010 Comparative Price Report detailing its annual survey of medical costs... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6038 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6038 Mon, 22 Nov 2010 17:16:00 +0000 LONDON, November 18, 2010 /PRNewswire/ -- Medivir AB (OMX: MVIR), the emerging research-based specialty pharmaceutical company focused on infectious diseases, will today host an R&D day for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6011 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/6011 Thu, 18 Nov 2010 06:10:00 +0000 LONDON, October 28, 2010 /PRNewswire/ -- Joel Fuhrman, M.D., a world leader in nutritional science, will share his discoveries leading to permanent weight loss and the reversal of chronic health... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5872 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5872 Thu, 28 Oct 2010 10:56:00 +0100 MCKINNEY, Texas, October 27, 2010 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended September 30, 2010, net income was $1.41 per share compared with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5870 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5870 Wed, 27 Oct 2010 21:00:00 +0100 ABBOTT PARK, Illinois, October 20, 2010 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2010. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5832 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5832 Wed, 20 Oct 2010 12:44:00 +0100 DUBLIN, October 18, 2010 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce third quarter 2010 earnings on Friday 29 October,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5813 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5813 Mon, 18 Oct 2010 16:51:00 +0100 WASHINGTON,, September 16, 2010 /PRNewswire/ -- CID s.r.l., a European company leader in interventional medicine, will update interventional cardiologists on the status of their revolutionary... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5610 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5610 Thu, 16 Sep 2010 15:45:00 +0100 DUBLIN, August 4, 2010 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to June 30, 2010. (1)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5383 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5383 Wed, 04 Aug 2010 12:27:00 +0100 LONDON, August 2, 2010 /PRNewswire/ -- Widespread capital freezes and financial shortcomings in the healthcare industry have caused a significant decline in the number of Digital Radiography (DR)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5374 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5374 Mon, 02 Aug 2010 08:00:00 +0100 MCKINNEY, Texas, July 28, 2010 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended June 30, 2010, net income was US$1.53 per share compared with US$1.38 per... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5368 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5368 Wed, 28 Jul 2010 21:00:00 +0100 ABBOTT PARK, Illinois, July 21, 2010 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5339 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5339 Wed, 21 Jul 2010 12:50:00 +0100 DUBLIN, July 15, 2010 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce second quarter 2010 earnings on Wednesday August 4, 2010. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5316 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5316 Thu, 15 Jul 2010 12:00:00 +0100 CALGARY, Canada, June 7, 2010 /PRNewswire/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that a poster presentation covering updated results of its Phase... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5025 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/5025 Mon, 07 Jun 2010 12:30:00 +0100 MEMPHIS, Tennessee, May 4, 2010 /PRNewswire/ -- In the news release, New Data Reinforces the Proven Safety and Effectiveness of the BIRMINGHAM HIP Resurfacing System, issued on 3 May 2010 23:22... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4810 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4810 Tue, 04 May 2010 05:35:00 +0100 MEMPHIS, Tennessee, May 4, 2010 /PRNewswire/ -- Recent new data(1) presented at this year's American Academy of Orthopaedic Surgeons (AAOS) annual meeting reinforces the BIRMINGHAM... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4809 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4809 Tue, 04 May 2010 00:22:00 +0100 DÜSSELDORF, Germany, April 29, 2010 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4797 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4797 Thu, 29 Apr 2010 14:24:00 +0100 LONDON, April 29, 2010 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces its results for the year ended 31 December 2009. On 5 January 2010, Silence... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4786 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4786 Thu, 29 Apr 2010 07:00:00 +0100 LONDON, April 28, 2010 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces that it will be releasing its preliminary results for the year ended 31 December... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4782 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4782 Wed, 28 Apr 2010 07:00:00 +0100 CHARENTON-LE-PONT, France, April 23, 2010 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced that consolidated revenue for the three months ended... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4756 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4756 Fri, 23 Apr 2010 06:20:00 +0100 LONDON, April 15, 2010 /PRNewswire/ -- According to the International Diabetes Federation the adult population with diabetes in 2010 is likely to reach 55.2 million in Europe and around 285... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4702 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4702 Thu, 15 Apr 2010 10:00:00 +0100 CHARENTON-LE-PONT, France, March 4, 2010 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4502 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4502 Thu, 04 Mar 2010 07:15:00 +0000 DUBLIN, February 19, 2010 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the year to December 31, 2009. Financial... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4429 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4429 Fri, 19 Feb 2010 12:00:00 +0000 CALGARY, Canada, February 16, 2010 /PRNewswire/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that it has received a letter of approval from the U.K. Medicines... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4416 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4416 Tue, 16 Feb 2010 12:30:00 +0000 MCKINNEY, Texas, February 8 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Fourth Quarter 2009 earnings after the market closes on Wednesday, February 10, 2010. In conjunction with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4371 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4371 Mon, 08 Feb 2010 12:00:00 +0000 LONDON and PALO ALTO, California, February 5 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) today announced that Philip Haworth, Ph.D., chief executive officer, will deliver a corporate... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4367 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4367 Fri, 05 Feb 2010 07:00:00 +0000 LONDON, February 2 /PRNewswire/ -- Business Analytics and Intelligence Systems are on the rise in the European healthcare industry. By managing medical data better effectively and faster, these... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4345 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4345 Tue, 02 Feb 2010 09:34:00 +0000 FRAZER, Philadelphia, AESCH, Switzerland and MAISONS ALFORT, France, February 1 /PRNewswire/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that it has signed an agreement to acquire Mepha AG... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4333 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4333 Mon, 01 Feb 2010 13:06:00 +0000 LAKE FOREST, Illinois and CHENNAI, India, December 15 /PRNewswire/ -- -- Strengthens Hospira's Manufacturing, Research and Development Capabilities; Enhances Orchid's Financial Flexibility to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4149 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4149 Tue, 15 Dec 2009 16:49:00 +0000 PEMBROKE, Bermuda, November 5 /PRNewswire/ -- Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today reported net income of $200.6 million, or $3.83 per diluted share, for the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3939 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3939 Thu, 05 Nov 2009 23:19:00 +0000 DUBLIN, October 30 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to September 30, 2009. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3901 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3901 Fri, 30 Oct 2009 13:08:00 +0000 MCKINNEY, Texas, October 28 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended September 30, 2009, net income was US$1.22 per share compared with US$.72... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3887 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3887 Wed, 28 Oct 2009 20:00:00 +0000 MCKINNEY, Texas, October 27 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Third Quarter 2009 earnings after the market closes on Wednesday, October 28, 2009. In conjunction with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3876 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3876 Tue, 27 Oct 2009 11:00:00 +0000 RALEIGH, North Carolina, October 26 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that its Vice President of Clinical Affairs for Early Development... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3869 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3869 Mon, 26 Oct 2009 12:30:00 +0000 MCKINNEY, Texas, October 26 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Third Quarter 2009 earnings after the market closes on Wednesday, October 28, 2009. In conjunction with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3866 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3866 Mon, 26 Oct 2009 11:00:00 +0000 CHARENTON-LE-PONT, France, October 22 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3846 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3846 Thu, 22 Oct 2009 06:25:00 +0100 CALGARY, Canada, September 25 /PRNewswire/ -- Resverlogix Corp. (TSX:RVX) announced today that it will host a live teleconference and webcast on Tuesday, September 29, 2009 at 1:00... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3721 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3721 Fri, 25 Sep 2009 18:21:00 +0100 THOUSAND OAKS, California, September 22 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced detailed results from the Phase 3 '181' trial evaluating Vectibix(R) (panitumumab) in combination with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3684 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3684 Tue, 22 Sep 2009 08:28:00 +0100 THOUSAND OAKS, California, September 21 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3675 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3675 Mon, 21 Sep 2009 10:53:00 +0100 THOUSAND OAKS, California, September 16 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced it will present detailed data from four Phase 3 studies as well as other data at the ECCO 15 - ESMO 34... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3657 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3657 Wed, 16 Sep 2009 14:56:00 +0100 OSLO, September 3 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3572 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3572 Thu, 03 Sep 2009 07:00:00 +0100 LONDON, August 25 /PRNewswire/ -- Chronic wounds cause immense suffering, healthcare expenditure, and disability for millions of patients - and make the wound care market a billion dollar market.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3511 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3511 Tue, 25 Aug 2009 12:19:00 +0100 AMSTERDAM, August 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2009. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3465 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3465 Thu, 13 Aug 2009 06:00:00 +0100 LONDON, August 5 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to June 30, 2009. Q2 2009 Financial... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3443 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3443 Wed, 05 Aug 2009 13:26:00 +0100 ABU DHABI, UAE, August 3 /PRNewswire/ -- The region's first and only summit on military medicine, Defence Healthcare 2009 will be held from 22nd - 25th November 2009 at the Hilton Hotel in Abu... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3429 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3429 Mon, 03 Aug 2009 07:00:00 +0100 LONDON, July 28 /PRNewswire/ -- In order to increase productivity, healthcare providers have started to integrate many IT-based ancillary systems such as EMR, HIS and PACS. So far, this has purely... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3414 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3414 Tue, 28 Jul 2009 10:00:00 +0100 CHARENTON-LE-PONT, France, July 17 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3386 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3386 Fri, 17 Jul 2009 06:37:00 +0100 PEMBROKE, Bermuda, July 8 /PRNewswire/ -- Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today announced that it will release its financial results for the second quarter ended June 30,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3345 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3345 Wed, 08 Jul 2009 14:33:00 +0100 NEW BRUNSWICK, New Jersey and DUBLIN, July 2 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) and Elan Corporation plc (NYSE: ELN) today announced a definitive agreement whereby Johnson &... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3321 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3321 Thu, 02 Jul 2009 12:51:00 +0100 NEW ORLEANS, June 5 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3166 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3166 Fri, 05 Jun 2009 09:30:00 +0100 LONDON, May 27 /PRNewswire/ -- The incidence of cardiovascular disease is rising due to factors such as ageing, obesity, smoking and other cardiac ailments. Each year cardiovascular diseases cause... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3115 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3115 Wed, 27 May 2009 11:00:00 +0100 NAPA, California, May 15 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3056 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3056 Fri, 15 May 2009 21:30:00 +0100 CAPE TOWN, South Africa, May 11 /PRNewswire/ -- Africa's healthcare markets are starting to feel the effects of the global economic slowdown. Pressures from the global environment have led... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3032 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3032 Mon, 11 May 2009 09:00:00 +0100 PHILADELPHIA and DUBLIN, April 30 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to March 31, 2009. ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2977 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2977 Thu, 30 Apr 2009 12:00:00 +0100 MCKINNEY, Texas, April 24 /PRNewswire/ -- Contact: Davida Walls of TORCHMARK CORPORATION, +1-972-569-3775 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2944 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2944 Fri, 24 Apr 2009 12:45:00 +0100 CHARENTON-LE-PONT, France, April 23 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR840.4 million for the three... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2934 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2934 Thu, 23 Apr 2009 06:25:00 +0100 MCKINNEY, Texas, April 22 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended March 31, 2009, net income was US$.91 per share (after a charge of US$.49... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2931 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2931 Wed, 22 Apr 2009 21:01:00 +0100 DUBLIN, Ireland, April 20 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce first quarter 2009 earnings on Thursday April 30, 2009. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2913 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2913 Mon, 20 Apr 2009 17:41:00 +0100 PARIS, March 25 /PRNewswire/ -- Hello, The investor meeting relating to the 2008 earnings and 2009 outlook has been webcasted. The presentation is available in English from the following link: http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2781 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2781 Wed, 25 Mar 2009 17:43:00 +0000 BRITISH COLUMBIA, Canada, March 3 /PRNewswire/ -- InNexus Biotechnology Inc. (Toronto Stock Exchange: IXS.V), a drug development company commercializing the next generation of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2661 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2661 Tue, 03 Mar 2009 21:46:00 +0000 MCKINNEY, Texas, February 19 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) announced today that its Chief Executive Officer, Mark McAndrew, and Chief Financial Officer, Gary Coleman, will... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2582 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2582 Thu, 19 Feb 2009 18:40:00 +0000 LONDON, February 17 /PRNewswire/ -- The Chemicals Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on Medical Trends Impacting the Chemicals... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2559 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2559 Tue, 17 Feb 2009 10:50:00 +0000 LONDON, February 16 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the European Cardiac Rhythm Management... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2555 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2555 Mon, 16 Feb 2009 11:37:00 +0000 SAN FRANCISCO, February 12 /PRNewswire/ -- Coverity, Inc. announces the following TechOnline Webinar: Overview: http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2546 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2546 Thu, 12 Feb 2009 14:00:00 +0000 PHILADELPHIA and DUBLIN, Ireland, February 9 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce full year 2008 earnings on... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2530 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2530 Mon, 09 Feb 2009 12:00:00 +0000 MCKINNEY, Texas, February 2 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Fourth Quarter 2008 earnings after the market closes on Wednesday, February 4, 2009. In conjunction with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2507 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2507 Mon, 02 Feb 2009 12:45:00 +0000 MUMBAI, India, January 30 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) reported continuing growth for the third quarter... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2500 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2500 Fri, 30 Jan 2009 16:58:00 +0000 SAN DIEGO, January 30 /PRNewswire/ -- Gen-Probe Incorporated (Nasdaq: GPRO), a pioneer and leader in nucleic acid diagnostics for human disease, announced today that it has offered to acquire all... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2497 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2497 Fri, 30 Jan 2009 07:47:00 +0000 CHARENTON-LE-PONT, France, January 29 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR3,074.5 million for the year... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2493 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2493 Thu, 29 Jan 2009 07:03:00 +0000 REHOVOT, Israel; JERSEY CITY, New Jersey; PHILADELPHIA, December 22 /PRNewswire/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2341 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2341 Mon, 22 Dec 2008 13:00:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, December 5 /PRNewswire/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG), an innovative molecular diagnostic company leveraging microRNAs as biomarkers,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2259 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2259 Fri, 05 Dec 2008 12:30:00 +0000 MONTR http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2246 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2246 Wed, 03 Dec 2008 22:52:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, December 2 /PRNewswire/ -- In the news release, "Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results" issued on... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2234 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2234 Tue, 02 Dec 2008 13:30:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, November 26 /PRNewswire/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release third quarter financial results on December 5, 2008,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2206 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2206 Wed, 26 Nov 2008 21:30:00 +0000 NAPA, California, November 14 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2135 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2135 Fri, 14 Nov 2008 21:30:00 +0000 LONDON, November 11 /PRNewswire/ -- Unilever is holding a two day Investor Seminar starting today, at Port Sunlight in the UK. Presentations will be webcast and available on Unilever's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2101 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2101 Tue, 11 Nov 2008 13:12:00 +0000 SYDNEY, November 10 /PRNewswire/ -- iSOFT, an IBA Health Group Limited (ASX: IBA) company, today announced the global launch of LORENZO, the next generation software solution for healthcare... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2094 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2094 Mon, 10 Nov 2008 23:00:00 +0000 LONDON, November 10 /PRNewswire/ -- In these uncertain economic times, pharmaceutical organisations are dramatically re-evaluating their business models. The need for highly competitive cost... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2083 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2083 Mon, 10 Nov 2008 11:00:00 +0000 SAN MATEO, California, October 29 /PRNewswire/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2019 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2019 Wed, 29 Oct 2008 20:29:00 +0000 PHILADELPHIA, Pennysylvania and DUBLIN, Ireland, October 29 /PRNewswire/ -- Shire plc (LSE: SHP)(NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2011 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2011 Wed, 29 Oct 2008 12:42:00 +0000 CHARENTON-LE-PONT, France, October 23 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1968 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1968 Thu, 23 Oct 2008 06:28:00 +0100 MCKINNEY, Texas, October 20 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Third Quarter 2008 earnings after the market closes on Wednesday, October 22, 2008. In conjunction with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1936 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1936 Mon, 20 Oct 2008 13:00:00 +0100 SAN DIEGO, September 3 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced that the company will present corporate updates at a number of upcoming industry... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1621 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1621 Wed, 03 Sep 2008 12:30:00 +0100 CHARENTON-LE-PONT, France, August 28 /PRNewswire/ -- The Board of Directors of Essilor International, the world leader in ophthalmic optics, has approved the financial statements for the six... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1584 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1584 Thu, 28 Aug 2008 06:36:00 +0100 ROCKVILLE, Maryland, August 26 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) announced today favorable results from the second stage of the Phase I/IIa human clinical trial of its... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1568 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1568 Tue, 26 Aug 2008 13:00:00 +0100 NYON, Switzerland, August 25 /PRNewswire/ -- Mymetics Corporation (OTC: MYMX), will be holding an important conference call on Wednesday August 27th 2008 at 1 PM New York Time to update all... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1558 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1558 Mon, 25 Aug 2008 11:51:00 +0100 REHOVOT, Israel and JERSEY CITY, New Jersey, August 19 /PRNewswire/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based diagnostic and therapeutic products, reported... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1542 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1542 Tue, 19 Aug 2008 09:30:00 +0100 NAPA, California, August 14 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1535 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1535 Thu, 14 Aug 2008 21:15:00 +0100 AMSTERDAM, August 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2008. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1511 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1511 Wed, 13 Aug 2008 11:38:00 +0100 AMSTERDAM, August 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2008. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1528 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1528 Wed, 13 Aug 2008 11:38:00 +0100 AMSTERDAM, The Netherlands, August 5 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it will release... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1483 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1483 Tue, 05 Aug 2008 06:00:00 +0100 COPENHAGEN, July 31 /PRNewswire/ -- Genmab A/S (OMX: GEN) and GlaxoSmithKline (LSE and NYSE: GSK) announced today positive top-line results from an interim analysis of the Phase III pivotal... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1475 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1475 Thu, 31 Jul 2008 17:17:00 +0100 LONDON, July 24 /PRNewswire/ -- Key Highlights Misys plc (FTSE: MSY.L) delivers results ahead of expectations and is now raising targets for the next phase of the turnaround. Misys generated... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1442 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1442 Thu, 24 Jul 2008 07:00:00 +0100 BASINGSTOKE, England and PHILADELPHIA, July 4 /PRNewswire/ -- Shire Limited (LSE:SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce second quarter 2008 earnings on... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1350 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1350 Fri, 04 Jul 2008 12:00:00 +0100 BASINGSTOKE, England and CAMBRIDGE, Massachusetts, July 3 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1338 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1338 Thu, 03 Jul 2008 08:30:00 +0100 MOUNTAIN VIEW, California, June 20 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that its corporate presentation will be webcast live during the Piper Jaffray... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1255 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1255 Fri, 20 Jun 2008 00:17:00 +0100 SAN DIEGO, June 3 /PRNewswire/ -- Gen-Probe Incorporated (Nasdaq: GPRO), a pioneer and leader in nucleic acid diagnostics for human disease, announced today that it has launched a conditional... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1139 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1139 Tue, 03 Jun 2008 13:22:00 +0100 EDMONTON, Canada, June 3 /PRNewswire/ -- Isotechnika Inc. will hold a conference call to discuss final Phase 2b PROMISE kidney transplant data for the Company's lead immunosuppressive... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1138 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1138 Tue, 03 Jun 2008 12:00:00 +0100 COPENHAGEN, May 28 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today results for the three month period ended March 31, 2008. During this period, Genmab reported the following results: ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1084 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1084 Wed, 28 May 2008 19:20:00 +0100 REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, May 21 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1051 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1051 Wed, 21 May 2008 13:30:00 +0100 REHOVOT, Israel and JERSEY CITY, New Jersey, May 14 /PRNewswire/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release first quarter financial results on May 21, 2008, before the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/992 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/992 Wed, 14 May 2008 13:30:00 +0100 ST. DAVID'S, Bermuda, May 9 /PRNewswire/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended March 31, 2008. Revenue in the quarter ended March 31,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/957 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/957 Fri, 09 May 2008 12:00:00 +0100 CALGARY, Canada, May 5 /PRNewswire/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that its 2008 Annual and Special Meeting of the Shareholders will be held on Wednesday, May... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/917 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/917 Mon, 05 May 2008 12:30:00 +0100 PRINCETON, New Jersey and MILAN, Italy, April 25 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces the results of a 4-week Phase 1 clinical trial evaluating two oral dose levels of R7128... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/870 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/870 Fri, 25 Apr 2008 16:30:00 +0100 PRINCETON, New Jersey and MILAN, Italy, April 24 /PRNewswire/ -- -- Two 4-week cohorts will be enrolled to evaluate R7128 1500mg BID in HCV genotypes 2 and 3 prior non-responders and R7128 1000mg... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/858 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/858 Thu, 24 Apr 2008 14:16:00 +0100 COPENHAGEN, April 22 /PRNewswire/ -- TopoTarget A/S (OMX: TOPO) today announced that the company has successfully gained full control of belinostat so that global rights are now wholly owned by... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/831 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/831 Tue, 22 Apr 2008 09:42:00 +0100 MCKINNEY, Texas, April 16 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended March 31, 2008, net income was US$1.29 per share compared with US$1.37 per... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/809 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/809 Wed, 16 Apr 2008 21:00:00 +0100 COPENHAGEN, Denmark, March 31 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today results for the financial year ended December 31, 2007. Revenues of DKK 530 million (approximately USD 104... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/648 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/648 Mon, 31 Mar 2008 22:18:00 +0100